doi:10.3969/j.issn.1671-2587.2018.01.035

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2018, Vol. 20 ›› Issue (1): 100-106.DOI: 10.3969/j.issn.1671-2587.2018.01.035

Previous Articles Next Articles

Received:2017-10-11 Online:2018-02-20 Published:2018-02-28

1 Silva Junior JM,Rezende E,Amendola C P,et al.Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy[J] .Sao Paulo Medical Journal,2012,130(2):77-83.
2 林振平,刘慧南,蔡旭兵,等.我国临床输血合理性文献的研究结果分析[J].医学与哲学,2015,36(2):51-54.
3 叶一冰.分析术中限制性输血与开放性输血的临床对比研究[J].医学信息,2012,25(12):114
4 魏晓玲,王雷,杨波.骨科围手术期限制性输血与开放性输血的临床疗效对比[J].四川医学,2015,36(9):1290-1292.
5 韩洪祯.术中限制性输血与开放性输血的临床对比[J].东南国防医药,2016,18(1):54-56.
6 吴先玉.术中限制性输血与开放性输血临床效果研究[J].医学信息,2015,28(37):381-382.
7 曾龙洪,李伟其,祁妙华,等.术中限制性输血与开放性输血临床分析[J].现代医院,2015,15(8):59-60.
8 邓丽丽,朱绍琼,张帆.骨科手术限制性输血与开放性输血的对比观察[J].遵义医学院学报,2014,37(6):644-646.
9 肖昆,乐爱平.创伤性脑损伤患者限制性输血治疗临床转归的预后研究[J].中国输血杂志,2015,28(8):933-935.
10 陈炜,孙建良,赵风庆,等.术中限制性输血与开放性输血的临床对比研究[J].上海医学,2012,35(4):284-286.
11 周恩娇.限制性输血在科学合理用血和节约血液资源中的作用分析[J].世界最新医学信息文摘(电子版),2015,38(15):251-253.
12 刘蕾.术中限制性输血与开放性输血的临床对比研究[J].医学信息,2015,28(3):305-306.
13 丁伟.术中限制性输血与开放性输血的临床对比分析[J].现代妇女(医学前沿),2014,(9):15.
14 吕国娟.术中限制性输血与开放性输血的临床对比分析[J].世界最新医学信息文摘(连续型电子期刊),2015,15(62):152-153.
15 吴密忠.对比术中限制性输血与开放性输血的效果观察[J].医药界(学术版),2014,(10).
16 马松波,侯春梅.限制性输血与开放性输血的临床应用体会[J].世界最新医学信息文摘,2015,96(15):49-51.
17 陈胜.术中限制性输血与开放性输血的临床对比研究[J].现代养生B,2014,35(14):38-39.
18 谢晓峰.术中限制性输血与开放性输血的临床对比研究[J].中国社区医师,2015,31(3):80-81.
19 李晓明,何立鹃.术中限制性输血和开放性输血的临床效果比较探析[J].世界最新医学信息文摘,2016,16(58):104.
20 Bhsakar B,Dulhunty J,Mullany DV,et al.Impact of blood product transfusion on short and long-term survival after cardiac surgery:more evidence[J].Ann Thorac Surg,2012,94(2):460-467.
21 Bracey AW,Radovancevic R,Riggs SA,et al.Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome[J].Transfusion,1999,39(10):1070-1077.
22 钟标,魏崴.体外循环心脏手术限制输血的回顾性研究[J].中国实用医药,2015,10(24):1-3.
23 吴沁娟,周荣华,刘斌. 心脏手术患者输血策略的系统评价[J]. 生物医学工程学杂志,2014,31(2):319-326.
24 Pull Ter Gunne AF,Skolasky RL,Ross H,et al.Influence of perioperative resuscitation status on post operativespine surgery complica[J].Spine Journal,2010,10(2):129-135.
25 Grover M,Talwalkar S,Casbard A,et al.Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty[J].Vox Sanguinis,2006,90(2):105-112.
26 Foss NB,Kristensen MT,Jansen PS,et al.The effect of liberal versus restrictive transfusion threshold in hip fracture surgery[J].Transfusion,2009,49(2):227-234.
27 涂源泉,姚富柱,马海莉,等. 产科限制性输血策略的临床研究[J]. 云南医药,2015,36(3):268-270.
28 张莉英,范琦慧,陈安儿,等. 限制性成分输血在重型胎盘早剥合并弥漫性血管内凝血救治中的价值[J]. 中国实用妇科与产科杂志,2012,28(11):854-856.
29 郭娜,秦再生,叶靖,等.限制性输液在妇科腹腔镜手术中的初步应用[J].数理医药学杂志,2013,26(1):32-34.
30 Tartter PI,Burrows L,Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer[J].Thorac Cardiovasc Surg,1984,88(5):659-662.
31 谢姆孜牙•买买提热夏提,沙吉伐木•买买提,刘昱,等.围手术期输血对肝恶性肿瘤术后复发率的影响[J].临床血液学杂志,2015,28(2): 652-653.
32 Waymack JP,Fernandes G,Yurt RW,et al.Effect of blood transfusions on immune function .Part Ⅵ .Effect on immunologic response to tumor[ J] .Surgry,1990 ,108(2):172-177 .
33 Blumberg N,Heal J,Chuang C,et al.Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence[J] .Ann Surg,1988,207(4):410-415.
34 杨世光,吴小东,周静,等.不同血红蛋白输血指征对中老年肿瘤手术患者的影响[J].中国输血杂志,2009,22(8):632-636.
35 刘永朱,张银华.不同输血指征对532 例肿瘤患者手术的影响[J].医药前沿,2015,2(10): 225-226.
36 廖刃,刘进.围手术期血液管理:由限制性输血走向个体化输血[J].中华医学杂志,2014,94(7):481-482.
37 刘德行,张秋英,张帆,等.改良限制性输血策略指导急诊围术期红细胞输注初探[J].中国输血杂志,2015,9(28):1006-1009.
38 38 苏秀琼,蓝健崇,刘丽芬,等.围术期指针评分知道输血方案的安全性与有效性研究[J].齐齐哈尔医学院学报,2013,34(20):2982-2984.
39 谢本发,方卫平,朱燕,等.围术期输血指针评分方案在妇科手术中的运用[J].安徽医科大学学报,2016,50(1):126-129.
40 张帆,朱绍琼,刘德行,等.围术期输血指针评分安全性与有效性研究[J].遵义医学院学报,2012,35(4):298-301.
41 41 袁强.不同输血指征对重症监护患者预后的影响观察[J].中国药物经济学,2012,39(6):343-34.
42 周玉洁.不同输血指征对重症监护病人预后的影响[J].当代医学,2012,30(18):56.
43 庄丽碧.使用限制性输血策略与开放性输血策略对ICU贫血患者进行输血对其预后的影响[J].当代医药论著,2015,12(13):290-291.
44 赖顺华,刘汉平,蔡国斌,等.不同输血指征对重症监护病人预后的影响研究[J].中外健康文摘,2013,20(10):162.
45 王慧,袁世荧,伍静.不同输血策略对ICU贫血患者预后的影响[J].临床急诊杂志,2014,4(15):205-207.
46 吴林伯,曾群娟,徐煜.分析不同输血指征对重症监护患者预后影响[J].中国社区医师,2015,32(31):38-39.
47 Hebert PC,Wells G,Blajchman MA,et al.A multicenter,randomized,controled clinical trial of transfusion requirements incritical care.Transfusion requirements in critical care investigators,Canadian critical care trials group[J]. N Engl J Med,1999,340(6):409-417.
48 Walsh TS,Boyd JA,Watson D,et al.Restrictive Versus Liberal Transfusion Strategies for Older Mechanically Ventilated Critically Ill Patients: A Randomized Pilot[J].Crit Care Med,2013,41(10):2354-2363.
49 Lacroix,J,Hébert PC,Hutchison JS,et al.Transfusion strategies for patients in pediatric intensive care units[J].New Engl J Med.2007,356(16):1609-1619.
50 李志强.危重病患者个体化输血策略与管理[J].临床输血与检验,2016,18(2):97-100.
51 孙俊波,陆应玉.某三甲医院2014年临床应用洗涤红细胞的调查分析[J].临床输血与检验,2016,18(2):173-175.
52 邵宗鸿,郑萌颖.自身免疫性溶血性贫血治疗进展[J]. 临床血液学杂志,2016,29(6):855-860.
53 安青,安霞.自身免疫性溶血性贫血患者输血中应注意的问题[J]. 山东医药,1999,39(11):14.
54 杨春会,田新,殷海斌,等. 儿童自身免疫性溶血性贫血的治疗进展[J]. 临床医学工程,2014,21(10):1365-1366.
55 黄文荣. 贫血的输血治疗[J]. 中国临床医生杂志,2014,(11):9-10.
56 任少敏,张秀萍,王同显. 非输血依赖性地中海贫血患者的输血治疗[J]. 中国输血杂,2016,29(11):1293-1296.
57 57 Cao,A. Galanello R. Galanello,Beta-thalassemia[J].Genetics in Medicine,2010,12(2) :61-76.
58 朱易萍. 地中海贫血的规范化输血治疗[J]. 中国输血杂志,2010,23(1):4-6.
59 中华医学会儿科学分会血液学组.《中华儿科杂志》编辑委员会.重型β地中海贫血的诊断和治疗指南[J].中华儿科杂志,2010,48(3):186-189.
60 梁秋.我国地中海贫血诊治进展与现状[J].临床医学研究与实践,2016,1(24):195-196.
61 苏金玉,翟惠敏.β地中海贫血输血治疗的研究进展[J].广东医学,2011,32(15):2063-2065.

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[3]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[4]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[5]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[6]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[7]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[8]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[13]	HAO Yi-wen. Evaluating Indications for Red Blood Cell Transfusion and Therapeutic Efficacy:An Overall and Dynamic View [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 590-593.
[14]	HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 613-616.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact